Commentary & Opinion by R. Lewis Dark
- Labs Have Questions about Prostate Biopsy Policy
- Changed Medicare Policy Adds to Regulatory Risk
- Lawyer Advises on Risk Of Prostate Biopsy Audits
- CLMA Asks Labs for Examples of RAC Auditor Overreach
- Competitive Bidding: Once Again, It’s Back!
- Sonic Healthcare, Bio-Reference Report Financial Performance
- Lab Specimen Transport Eliminates Need for Ice